Skip to main content
Helixmith Co., Ltd logo

Helixmith Co., Ltd — Investor Relations & Filings

Ticker · 084990 ISIN · KR7084990001 KO Manufacturing
Filings indexed 508 across all filing types
Latest filing 2019-05-28 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 084990

About Helixmith Co., Ltd

https://www.helixmith.com/

Helixmith is a biotechnology company specializing in the research and development of gene therapies. Established in 1996, the company focuses on creating innovative biopharmaceuticals for diseases with significant unmet medical needs. Its core activities revolve around an extensive pipeline of next-generation gene therapy products. The primary therapeutic areas of focus include neurological and cardiovascular disorders, such as peripheral artery disease and coronary artery disease. Helixmith manages a comprehensive range of capabilities, from discovery and preclinical studies to clinical development of its drug candidates.

Recent filings

Filing Released Lang Actions
주요사항보고서(유무상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Financial Services Commission and Korea Exchange. It details a decision regarding a capital increase (both paid-in and bonus issuance/유무상증자결정). This type of regulatory filing, which announces specific corporate actions like capital changes, falls under the 'Share Issue/Capital Change' category.
2019-05-28 Korean
주권매매거래정지(무상증자)
Share Issue/Capital Change Classification · 95% confidence The document is a short regulatory notice regarding the suspension of stock trading ('주권매매거래정지') for Helixmith due to a bonus issue ('무상증자'). It cites specific KOSDAQ market regulations and provides the duration of the suspension. As it is a regulatory announcement regarding trading status and does not fit into specific categories like M&A or share issuance, it is classified as a general regulatory filing.
2019-05-28 Korean
[기재정정]사업보고서 (2018.12)
Annual Report Classification · 100% confidence The document is a 'Correction Report' (정정신고) for a previously filed 2018 Annual Report (사업보고서). It explicitly lists the sections being corrected (e.g., shareholder information, executive compensation, subsidiary investments, and use of proceeds) and provides the 'before' and 'after' data. Since it is a formal amendment to an Annual Report containing substantive financial and operational data, it is classified as a 10-K (Annual Report) filing type. FY 2018
2019-05-17 Korean
기타경영사항(특허권취득)(자율공시)(간세포 성장인자 및 기질세포 유발인자1알파를 포함하는 말초동맥질환의 예방 또는 치료용 조성물)
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from a Korean company (Helixmith) announcing the acquisition of a patent for a pharmaceutical composition. It is categorized as a 'Regulatory Filing' (RNS) because it is a specific corporate disclosure regarding business operations (patent acquisition) that does not fit into the more specialized categories like M&A, financial reports, or director dealings.
2019-05-17 Korean
분기보고서 (2019.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'Helixmith' (formerly Viromed) for the period ending March 31, 2019. It contains detailed financial statements, business descriptions, capital structure, and management discussions, which are characteristic of a comprehensive interim financial report. It is not an announcement of a report, but the report itself. Q1 2019
2019-05-15 Korean
파생상품거래손실발생
Capital/Financing Update Classification · 95% confidence The document is a regulatory disclosure from Helixmith regarding a 'Loss from Derivatives Transaction' (파생상품거래손실발생). It details a specific financial event (valuation loss on convertible bonds) and is filed with the Korea Exchange (KRX). Since it is a specific regulatory disclosure of a financial event that does not fit into standard periodic reports, dividend announcements, or management changes, it falls under the general regulatory filing category.
2019-05-15 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.